Efficacy of mosapride citrate with polyethylene glycol solution for colonoscopy preparation
Open Access
- 1 January 2012
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (20) , 2517-25
Abstract
AIM: To evaluate the efficacy and safety of adjunctive mosapride citrate for bowel preparation before colonoscopy. METHODS: We conducted a randomized, double-blind, placebo-controlled study with mosapride in addition to polyethylene glycol (PEG)-electrolyte solution. Of 250 patients undergoing colonoscopy, 124 were randomized to receive 2 L PEG plus 15 mg of mosapride citrate (mosapride group), and 126 received 2 L PEG plus placebo (placebo group). Patients completed a questionnaire reporting the acceptability and tolerability of the bowel preparation process. The efficacy of bowel preparation was assessed by colonoscopists using a 5-point scale based on Aronchicks criteria. The primary end point was optimal bowel preparation rates (scores of excellent/good/fair vs poor/inadequate). RESULTS: A total of 249 patients were included in the analysis. In the mosapride group, optimal bowel preparation rates were significantly higher in the left colon compared with the placebo group (78.2% vs 65.6%, P < 0.05), but not in the right colon (76.5% vs 66.4%, P = 0.08). After excluding patients with severe constipation, there was a significant difference in bowel preparation in both the left and right colon (82.4% vs 66.7%, 80.8% vs 67.5%, P < 0.05, P < 0.01). The incidence of adverse events was similar in both groups. Among the subgroup who had previous colonoscopy experience, a significantly higher number of patients in the mosapride group felt that the current preparation was easier compared with patients in the placebo group (34/72 patients vs 24/74 patients, P < 0.05). CONCLUSION: Mosapride citrate may be an effective and safe adjunct to PEG-electrolyte solution that leads to improved quality of bowel preparation, especially in patients without severe constipationKeywords
This publication has 34 references indexed in Scilit:
- [Serotonin 5- HT4 receptor agonist (mosapride citrate)].2006
- A consensus document on bowel preparation before colonoscopy: Prepared by a Task Force From The American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)Gastrointestinal Endoscopy, 2006
- The administration of cisapride as an adjuvant to PEG-electrolyte solution for colonic cleansing: a double-blind randomized study.2005
- Mosapride citrate, a novel 5‐HT4 agonist and partial 5‐HT3 antagonist, ameliorates constipation in parkinsonian patientsMovement Disorders, 2005
- Controlled study of cisapride-assisted lavage preparatory to colonoscopyGastrointestinal Endoscopy, 1998
- Long‐term results with cisapride in Parkinson's diseaseMovement Disorders, 1997
- The effects of cisapride on the quality and tolerance of colonic lavage: a double-blind randomized studyGastrointestinal Endoscopy, 1995
- Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects.1993
- Senna vs. bisacodyl in addition to Golytely lavage for colonoscopy preparation--a prospective randomized trial.1992
- Prokinetic effect of AS-4370 on gastric emptying in healthy adultsEuropean Journal of Clinical Pharmacology, 1991